Laurion Capital Management’s Sanara MedTech SMTI Stock Holding History

Laurion Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,805	Closed	-$350K	–	543
2022 Q3	$350K	Hold	11,805	–	–	﹤0.01%	416
2022 Q2	$246K	Sell	11,805 -2,784	-19%	-$65K	﹤0.01%	379
2022 Q1	$405K	Sell	14,589 -10,458	-42%	-$265K	0.01%	400
2021 Q4	$762K	Sell	25,047 -2,977	-11%	-$93.7K	0.01%	373
2021 Q3	$954K	Sell	28,024 -5,575	-17%	-$200K	﹤0.01%	520
2021 Q2	$1.24M	Sell	33,599 -14,801	-31%	-$433K	0.01%	414
2021 Q1	$1.51M	Buy	+48,400	New	+$1.68M	0.01%	452

Other funds holding SMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

NRC

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Laurion Capital Management's SMTI Position: Q4 2022 in Review

Laurion Capital Management sold out of Sanara MedTech (SMTI) in Q4 2022, closing a stake of 11,805 shares — an estimated $350K sold.

Laurion Capital Management first reported a position in SMTI in Q1 2021 and held it in 7 quarters. The position peaked at $1.51M in Q1 2021. 31 funds tracked by Wall St. Rank hold SMTI as of Q4 2022.

Laurion Capital Management reported no remaining Sanara MedTech position as of Q4 2022 after selling out during the quarter.
Laurion Capital Management sold 11,805 Sanara MedTech shares in Q4 2022, an estimated $350K.
Laurion Capital Management first reported a position in Sanara MedTech in Q1 2021 and held it in 7 quarters.
Laurion Capital Management's Sanara MedTech position peaked at $1.51M in Q1 2021.
31 funds tracked by Wall St. Rank held Sanara MedTech as of Q4 2022.

Based on Laurion Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.